Literature DB >> 10713710

Developmental expression of pim kinases suggests functions also outside of the hematopoietic system.

A Eichmann1, L Yuan, C Bréant, K Alitalo, P J Koskinen.   

Abstract

We have cloned a novel quail cDNA with strong homology to the pim family of proto-oncogenes. The deduced amino acid (aa) sequence of the cDNA, named qpim, is more closely related to Xenopus Pim and to the recently identified rat Pim-3 than to human or rodent Pim-1 or Pim-2. The protein encoded by the qpim cDNA can autophosphorylate itself and share substrates with murine Pim-1, suggesting functional redundancy to other Pim family serine/threonine kinases. We have compared the expression of qpim in avian embryos to mouse pim-1, -2 and -3 by in situ hybridization. qpim shows a highly dynamic expression pattern, particularly at early developmental stages. Surprisingly, its expression pattern is not identical to any of the murine pim genes, which show complementary and/or partially overlapping expression sites both in- and outside of the hematopoietic system. Altogether, our results suggest novel functions for Pim family kinases during embryonic development, in particular in epithelia and in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713710     DOI: 10.1038/sj.onc.1203355

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  41 in total

1.  Constitutive E2F1 overexpression delays endochondral bone formation by inhibiting chondrocyte differentiation.

Authors:  Blanca Scheijen; Marieke Bronk; Tiffany van der Meer; René Bernards
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

2.  Cardiovascular expression of the mouse WNK1 gene during development and adulthood revealed by a BAC reporter assay.

Authors:  Céline Delaloy; Juliette Hadchouel; Martine Imbert-Teboul; Maud Clemessy; Anne-Marie Houot; Xavier Jeunemaitre
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor.

Authors:  Mustapha Haddach; Jerome Michaux; Michael K Schwaebe; Fabrice Pierre; Sean E O'Brien; Cosmin Borsan; Joe Tran; Nicholas Raffaele; Suchitra Ravula; Denis Drygin; Adam Siddiqui-Jain; Levan Darjania; Ryan Stansfield; Chris Proffitt; Diwata Macalino; Nicole Streiner; Joshua Bliesath; May Omori; Jeffrey P Whitten; Kenna Anderes; William G Rice; David M Ryckman
Journal:  ACS Med Chem Lett       Date:  2011-12-27       Impact factor: 4.345

Review 4.  Why target PIM1 for cancer diagnosis and treatment?

Authors:  Nancy S Magnuson; Zeping Wang; Gang Ding; Raymond Reeves
Journal:  Future Oncol       Date:  2010-09       Impact factor: 3.404

5.  Identification of novel inhibitors for Pim-1 kinase using pharmacophore modeling based on a novel method for selecting pharmacophore generation subsets.

Authors:  Rand Shahin; Lubna Swellmeen; Omar Shaheen; Nour Aboalhaija; Maha Habash
Journal:  J Comput Aided Mol Des       Date:  2015-12-19       Impact factor: 3.686

6.  PIM1 gene cooperates with human BCL6 gene to promote the development of lymphomas.

Authors:  Beverly W Baron; John Anastasi; Elizabeth M Hyjek; Juraj Bies; Poluru L Reddy; Jingfang Dong; Loren Joseph; Michael J Thirman; Kristen Wroblewski; Linda Wolff; Joseph M Baron
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

7.  PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis.

Authors:  Xiu Feng Hu; Jie Li; Scott Vandervalk; Zeping Wang; Nancy S Magnuson; Pei Xiang Xing
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

8.  Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion.

Authors:  Niina M Santio; Riitta L Vahakoski; Eeva-Marja Rainio; Jouko A Sandholm; Sanna S Virtanen; Michelle Prudhomme; Fabrice Anizon; Pascale Moreau; Päivi J Koskinen
Journal:  Mol Cancer       Date:  2010-10-19       Impact factor: 27.401

9.  Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors.

Authors:  Harald Mikkers; Martijn Nawijn; John Allen; Conny Brouwers; Els Verhoeven; Jos Jonkers; Anton Berns
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

10.  Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes.

Authors:  Shannon M Mumenthaler; Patricia Y B Ng; Amanda Hodge; David Bearss; Gregory Berk; Sarath Kanekal; Sanjeev Redkar; Pietro Taverna; David B Agus; Anjali Jain
Journal:  Mol Cancer Ther       Date:  2009-10       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.